| pubmed-article:11401646 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11401646 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11401646 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:11401646 | lifeskim:mentions | umls-concept:C0007585 | lld:lifeskim |
| pubmed-article:11401646 | lifeskim:mentions | umls-concept:C1326205 | lld:lifeskim |
| pubmed-article:11401646 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:11401646 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:11401646 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11401646 | pubmed:dateCreated | 2001-6-12 | lld:pubmed |
| pubmed-article:11401646 | pubmed:abstractText | Experimental trials aimed at the research of selective antifibrotic agents are under development for the alternative treatment of glaucoma patients who are usually considered high-risk post-surgical individuals after trabeculectomy. Authors present here an in vitro model system for the treatment of post-trabeculectomy patients. The study is aimed at the evaluation of different drugs in a mouse fibroblast model. | lld:pubmed |
| pubmed-article:11401646 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11401646 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11401646 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11401646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11401646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11401646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11401646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11401646 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11401646 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11401646 | pubmed:issn | 1395-3907 | lld:pubmed |
| pubmed-article:11401646 | pubmed:author | pubmed-author:RisuleoGG | lld:pubmed |
| pubmed-article:11401646 | pubmed:author | pubmed-author:ScarsellaGG | lld:pubmed |
| pubmed-article:11401646 | pubmed:author | pubmed-author:PescosolidoNN | lld:pubmed |
| pubmed-article:11401646 | pubmed:author | pubmed-author:Cristofanilli... | lld:pubmed |
| pubmed-article:11401646 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11401646 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:11401646 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11401646 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11401646 | pubmed:pagination | 309-12 | lld:pubmed |
| pubmed-article:11401646 | pubmed:dateRevised | 2008-3-17 | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:meshHeading | pubmed-meshheading:11401646... | lld:pubmed |
| pubmed-article:11401646 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11401646 | pubmed:articleTitle | A murine cell culture model for post-trabeculectomy anfibrotic treatment: Induction of apoptosis by Cyclosporin. | lld:pubmed |
| pubmed-article:11401646 | pubmed:affiliation | Istituto di Oftalmologia, Università di Roma La Sapienza, Italy. | lld:pubmed |
| pubmed-article:11401646 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11401646 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11401646 | lld:pubmed |
